4-Hydroxyproline galactoside

Metabolite details

Identifier

OJEYXWIZDRJBDC-UHFFFAOYSA-N

InChI Key

OJEYXWIZDRJBDC-UHFFFAOYSA-N

IUPAC name

4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxypyrrolidine-2-carboxylic acid

Preferred name

4-Hydroxyproline galactoside

INN name

—

Synonym

—

ChEBI

CHEBI:173176

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Efficacy of Zhuyu Pill Intervention in a Cholestasis Rat Model: Mutual Effects on Fecal Metabolism and Microbial Diversity
• High complexity and diel dynamics of planktonic microbiome revealed by multi-omics in Taihu, China
• Transcriptome and Metabolome Analyses Reveal Differences in Terpenoid and Flavonoid Biosynthesis in Cryptomeria fortunei Needles Across Different Seasons
• Effects of Radiofrequency Field from 5G Communications on fecal microbiome and metabolome profiles in mice
• Intergenerational Association of Gut Microbiota and Metabolism between Perinatal Folic Acid Metabolism and Neural Tube Defects (Feces metabolomics)
• Interaction between Cervical Microbiota and Host Gene Regulation in Caesarean Section Scar Diverticulum
• Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
• Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

• Control_vs_CF_high
• 2:00 AM_Membrane_vs_2:00 AM_Net
• Summer_vs_Winter
• Sham_vs_Radiofrequency
• Normal_vs_Neural_Tube_Defect
• Control_vs_CSD
• Control_vs_ZYP_High_Dose
• Control_0d_vs_Treatment_180d